Revision of the EU general pharmaceutical legislation - addressing challenges, seizing opportunities

In March 2023, the European Commission is due to publish its proposal for the upcoming revision of the EU pharmaceutical legislation, to ensure a future-proof and crisis-resistant regulatory system.  In this event key, experts will consider the opportunities and lessons learned from the pandemic and discuss how to ensure the security of access to and supply of medicines for all even in times of crisis, while fostering innovation and investment in research and striving for a new dialogue between public and private sector.

This event was organised in close cooperation with the Federal Ministry of Social Affairs, Health, Care and Consumer Protection, Austria and the Permanent Representation of Austria to the European Union.